• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, November 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Study identifies a role for the metabolism regulator PPARγ in liver cancer

Bioengineer by Bioengineer
April 10, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Liver cancers are a major cause of cancer-related deaths. Large-scale genetic analyses have associated liver cancer with dysregulation of numerous molecular pathways, but disruptions in insulin signaling pathways appear to have a particularly important contribution to liver tumor formation. Obesity is a major risk factor for developing liver cancer, and the nuclear receptor PPARγ critically controls fat uptake and storage in the liver by regulating the transcription of metabolism-associated genes. However, whether PPARγ also plays a role in promoting the growth of liver tumors is not clear.

This week in the JCI, research led by Ganna Panasyuk at INSERM examined the link between PPARγ and liver tumor formation. The findings identify a metabolic pathway with pro-tumor effects that can be suppressed by selectively blocking PPARγ. Researchers initially observed that increases in PPARγ expression and activity in human liver tumors were associated with loss-of-function of the transcription factor hepatocyte nuclear factor 1α (HNF1α). In a mouse model, they determined that loss of HNF1α led to abnormal increases in PPARγ expression that in turn led to increased tumorigenesis. Pharmacological activation of PPARγ in a mouse model of liver cancer exacerbated tumor formation; in contrast, treatment with a PPARγ inhibitor had positive therapeutic effects.

Taken together, these findings demonstrate a role for PPARγ in the metabolic pathway disturbances that promote liver tumorigenesis and reveal that PPARγ is a potential target for anti-tumor therapies to treat liver cancers.

###

TITLE: Hepatocyte nuclear factor 1α suppresses steatosis- associated liver cancer by inhibiting PPARγ transcription

AUTHOR CONTACT:

Ganna Panasyuk
Institut Necker-Enfants Malades
INSERM U1151/CNRS UMR 8253 a href="mailto:[email protected]">[email protected]

View this article at: http://www.jci.org/articles/view/90327?key=f53576a87fd0165f5cb7

Media Contact

Elyse Dankoski
[email protected]
@jclinicalinvest

http://www.jci.org

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

Comparing Low and High-Tech Tools for Activity Schedules

November 1, 2025

Switching MS Patients: Anti-CD20 to Cladribine Tablets

November 1, 2025

Revolutionary ARDitox Uncovers Cross-Reactive TCR Epitopes

November 1, 2025

Cloud-Connected Tubeless Insulin Pump Improves Diabetes Management

November 1, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1294 shares
    Share 517 Tweet 323
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    312 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    203 shares
    Share 81 Tweet 51
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    137 shares
    Share 55 Tweet 34

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Comparing Low and High-Tech Tools for Activity Schedules

Switching MS Patients: Anti-CD20 to Cladribine Tablets

Revolutionary ARDitox Uncovers Cross-Reactive TCR Epitopes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.